Therapeutic Area Guidance

South Yorkshire Lipid Management Pathway

Lipid Modification for the primary prevention of CVD in Younger Adults (18-39) with Type 2 Diabetes

For COVID-19 information, click here.

SYICB Position Statement on the prescribing of gabapentinoids

Shared Care Protocol For Epilepsy in Adults

South Yorkshire Valproate Guidance

Shared Care Protocol For Alimemazine in the treatment of sleep disorders in Children

Opioid Prescribing Resource Including Tapering Advice

Topiramate review flowcharts

Neurology: Migraine Management

Rimegepant (Vydura®) Supporting information for Acute Treatment of Migraine in Adults

Rimegepant For Treating a Migraine Attack Patient Information

Guidance for Continuous Glucose Monitoring (CGM) in Adults and Children with Type 1 and Type 2 Diabetes

Shared Care Protocol For Denosumab 60mg/mL injection (Prolia®)

Shared Care Protocol Use of Liothyronine (T3) for the treatment of hypothyroidism in selected cohort of adults despite optimal dosage with levothyroxine and where alternative cause of symptoms have been excluded.

Interim Position Statement: Hybrid Closed Loop (HCL) position statement

Shared Care Protocol For Alimemazine in the treatment of sleep disorders in Children

Hybrid Closed Loops FAQ

Shared Care Protocol of Finerenone in patients with Chronic Kidney Disease and Type 2 Diabetes

SY Guidance for supporting women with type 2 diabetes to prepare for pregnancy

SY ICB Guideline for young adults with type 2 diabetes

Interim Position Statement for Tirzepatide for Managing Weight and Obesity

SY Tirzepatide Amber G guidelines

SY Gliptins position statement

Guidance for patients on HRT with unscheduled bleeding

Medicines with teratogenic potential

SY ICB Prescribing Guidance For Ibandronic Acid 50mg tablets as adjuvant therapy in early breast cancer

South Yorkshire gluten free guidelines

Yorkshire and Humber Palliative Care Guidance